Health Canada has approved a second drug that can slow the progression of Alzheimer’s disease. Donanemab, sold by American drugmaker Eli Lilly under the brand...
Over the past 10,000 years, natural selection has contributed to the evolution of nearly 500 genes in the DNA of West Eurasians, affecting their looks...
Novo Nordisk says the expiration of its patents for some semaglutide GLP-1 drug treatments in markets like Canada will result in more generics entering the...